Page 870 - Williams Hematology ( PDFDrive )

844 Part VI: The Erythrocyte Chapter 54: Hemolytic Anemia Resulting from Immune Injury 845

303. Issitt PD: Autoimmune hemolytic anemia and cold hemagglutinin disease: Clinical dis- 337. Ahn YS, Harrington WJ, Byrnes JJ, et al: Treatment of autoimmune hemolytic anemia
ease and laboratory findings. Prog Clin Pathol 7:137, 1978. with vinca-loaded platelets. JAMA 249:2189, 1983.
304. Wallhermfechtel MA, Pohl BA, Chaplin H: Alloimmunization in patients with warm 338. Oda H, Honda A, Sugita K, et al: High-dose intravenous intact IgG infusion in refrac-
autoantibodies: A retrospective study employing three donor alloabsorptions to aid in tory autoimmune hemolytic anemia (Evans syndrome). J Pediatr 107:744, 1985.
antibody detection. Transfusion 24:482, 1984. 339. Bussel JB, Cunningham-Rundles C, Abraham C: Intravenous treatment of autoimmune
305. Branch DR, Petz LD: Detecting alloantibodies in patients with autoantibodies. Transfu- hemolytic anemia with very high dose gammaglobulin. Vox Sang 41:264, 1986.
sion 39:6, 1999. 340. Besa EC: Rapid transient reversal of anemia and long-term effects of maintenance
306. Shirey RS, Boyd JS, Parwani AV, et al: Prophylactic antigen matched donor blood for intravenous immunoglobulin for autoimmune hemolytic anemia in patients with lym-
patients with warm autoantibodies: An algorithm for transfusion management. Trans- phoproliferative disorders. Am J Med 84:691, 1988.
fusion 42:1435, 2002. 341. Flores G, Cunningham-Rundles C, Newland AC, Bussel JB: Efficacy of intravenous
307. Garratty G, Petz LD: Approaches to selecting blood for transfusion to patients with immunoglobulin in the treatment of autoimmune hemolytic anemia: Results in 73
autoimmune hemolytic anemia. Transfusion 42:1390, 2002. patients. Am J Hematol 44:237, 1993.
308. Dameshek W, Rosenthal MC, Schwartz SO: The treatment of acquired hemolytic ane- 342. Ahn YS, Harrington WJ, Mylvaganam R, et al: Danazol therapy for autoimmune hemo-
mia with adrenocorticotrophic hormone (ACTH). N Engl J Med 244:117, 1951. lytic anemia. Ann Intern Med 102:298, 1985.
309. Allgood JW, Chaplin H Jr: Idiopathic acquired autoimmune hemolytic anemia: A 343. Pignon J-M, Poirson E, Rochant H: Danazol in autoimmune haemolytic anaemia. Br J
review of forty-seven cases treated from 1955 to 1965. Am J Med 43:254, 1967. Haematol 83:343, 1993.
310. Meyer O, Stahl D, Beckhove P, et al: Pulsed high-dose dexamethasone in chronic auto- 344. Giannadaki E, Potamianos S, Roussomoustakaki M, et al: Autoimmune hemolytic ane-
immune haemolytic anaemia of warm type. Br J Haematol 98:860, 1997. mia and positive Coombs’ test associated with ulcerative colitis. Am J Gastroenterol
311. Greendyke RM, Bradley EB, Swisher SN: Studies of the effects of administration of 92:1872, 1997.
ACTH and adrenal corticosteroids on erythrophagocytosis. J Clin Invest 44:746, 1965. 345. Cobo F, Pereira A, Nomdedeu B, et al: Ovarian dermoid cyst-associated autoimmune
312. Fries LF, Brickman CM, Frank MM: Monocyte receptors for the Fc portion of IgG hemolytic anemia. Am J Clin Pathol 105:567, 1996.
increase in number in autoimmune hemolytic anemia and other hemolytic states and 346. Berentsen S, Ulvestad E, Gjertsen BT, et al: Rituximab for primary cold agglutinin dis-
are decreased by glucocorticoid therapy. J Immunol 131:1240, 1983. ease: A prospective study of 37 courses of therapy in 27 patients. Blood 103:2925, 2004.
313. Habibi B, Homberg JC, Schaison G, Salmon C: Autoimmune hemolytic anemia in chil- 347. Schollkopf, C, Kjeldsen L, Bjerrum OW, et al: Rituximab in chronic cold agglutinin
dren: A review of 80 cases. Am J Med 56:61, 1974. disease: A prospective study of 20 patients. Leuk Lymphoma 47:253, 2006.
314. Christensen BE: The pattern of erythrocyte sequestration in immunohaemolysis: 348. Berentsen S, Randen U, Vagan AM, et al: High response rate and durable remissions
Effects of prednisone treatment and splenectomy. Scand J Haematol 10:120, 1973. following fludarabine and rituximab combination therapy for chronic cold agglutinin
315. Parker AC, MacPherson AIS, Richmond J: Value of radiochromium investigation in disease. Blood 116:3180, 2010.
autoimmune haemolytic anemia. Br Med J 1:208, 1977. 349. Hippe E, Jensen KB, Olesen H, et al: Chlorambucil treatment of patients with cold
316. Schwartz SI, Bernard RP, Adams JT, Bauman AW: Splenectomy for hematologic disor- agglutinin syndrome. Blood 35:68, 1970.
ders. Arch Surg 101:338, 1970. 350. Evans RS, Baxter E, Gilliland BC: Chronic hemolytic anemia due to cold agglutinins:
317. Eichner ER: Splenic function: Normal, too much and too little. Am J Med 66:311, 1979. A 20-year history of benign gammopathy with response to chlorambucil. Blood 42:463,
318. Centers for Disease Control and Prevention: Recommended adult immunization 1973.
schedule—United States 2003–2004. MMWR Morb Mortal Wkly Rep 52:965, 2003. 351. Gupta N, Wang ES: Long-term response of refractory primary cold agglutinin disease
319. Taylor RP, Lindorfer MA: Drug insight: The mechanism of action of rituximab in auto- to eculizumab therapy. Ann Hematol 93:343, 2014.
immune disease—The immune complex decoy hypothesis. Nat Clin Pract Rheumatol 352. Roth A, Huttmann A, Rother RP, et al: Long-term efficacy of the complement inhibitor
3:86, 2007. eculizumab in cold agglutinin disease. Blood 113:3885, 2009.
320. Garvey B: Rituximab in the treatment of autoimmune haematological disorders. Br J 353. Carson KR, Beckwith LG, Mehta J: Successful treatment of IgM-mediated autoimmune
Haematol 141:149, 2008. hemolytic anemia with bortezomib. Blood 115:915, 2010.
321. Zecca M, Nobili B, Ramenghi U, et al: Rituximab for the treatment of refractory auto- 354. Bell CA, Zwicker H, Sacks HJ: Autoimmune hemolytic anemia. Am J Clin Pathol
immune hemolytic anemia in children. Blood 101:3857, 2003. 60:903, 1973.
322. Bussone G, Ribeiro E, Dechartres A, et al: Efficacy and safety of rituximab in adults’ 355. Taft EG, Propp RP, Sullivan SA: Plasma exchange for cold agglutinin hemolytic anemia.
warm antibody autoimmune hemolytic anemia: Retrospective analysis of 27 cases. Am Transfusion 17:173, 1977.
J Hematol 84:153, 2009. 356. Brooks BD, Steane EA, Sheehan RG, Frenkel EP: Therapeutic plasma exchange in the
323. Barcellini W, Zaja F, Zaninoni A, et al: Low-dose rituximab in adult patients with idio- immune hemolytic anemias and immunologic thrombocytopenic purpura. Prog Clin
pathic autoimmune hemolytic anemia: Clinical efficacy and biologic studies. Blood Biol Res 106:317, 1982.
119:3691, 2012. 357. Silberstein LE, Berkman EM: Plasma exchange in autoimmune hemolytic anemia
324. Barcellini W, Zaja F, Zaninoni A, et al: Sustained response to low-dose rituximab in (AIHA). J Clin Apher 1:238, 1983.
idiopathic autoimmune hemolytic anemia. Eur J Haematol 91:546, 2013. 358. Zulian GB, Roux E, Tiercy J-M, et al: Transfusion-associated graft-versus-host dis-
325. Birgins H, Frederiksen H, Hasselbalch H, et al: A phase III randomized trial comparing ease in a patient treated with cladribine (2-chlorodeoxyadenosine): Demonstration of
glucocorticoid monotherapy versus glucocorticoid and rituximab in patients with auto- exogenous DNA in various tissue extracts by PCR analysis. Br J Haematol 89:83, 1995.
immune hemolytic anaemia. Br J Haematol 163:393, 2013. 359. Briz M, Cabrera R, Sanjuan I: Diagnosis of transfusion-associated graft-versus-host
326. Murphy S, LoBuglio AF: Drug therapy of autoimmune hemolytic anemia. Semin Hematol disease by polymerase chain reaction fludarabine-treated B-chronic lymphocytic leu-
13:323, 1976. kaemia. Br J Haematol 91:409, 1995.
327. Moyo VM, Smith D, Brodsky I, et al: High-dose cyclophosphamide for refractory auto- 360. Silverstein MN, Gomes MR, Elveback LR, et al: Idiopathic acquired hemolytic anemia:
immune hemolytic anemia. Blood 100:704, 2002. Survival in 117 cases. Arch Intern Med 129:85, 1972.
328. Beutler E: New chemotherapeutic agent: 2-Chlorodeoxyadenosine. Semin Hematol 361. Dausset J, Colombani J: The serology and the prognosis of 128 cases of autoimmune
31:40, 1994. hemolytic anemia. Blood 14:1280, 1959.
329. Kotb R, Pinganaud C, Trichet C, et al: Efficacy of mycophenolate mofetil in adult refrac- 362. Pullarkat V, Ngo M, Iqbal S, et al: Detection of lupus anticoagulant identifies patients
tory auto-immune cytopenias: A single center preliminary study. Eur J Haematol 75:60, with autoimmune haemolytic anaemia at increased risk of venous thromboembolism.
2005. Br J Haematol 118:1166, 2002.
330. Howard J, Hoffbrand AV, Prentice HG, Mehta A: Mycophenolate mofetil for the treat- 363. Hendrick AM: Auto-immune haemolytic anaemia—A high-risk disorder for thrombo-
ment of refractory auto-immune haemolytic anaemia and auto-immune thrombocy- embolism? Hematology 8:53, 2003.
topenic purpura. Br J Haematol 117:712, 2002. 364. Buchanan GR, Boxer LA, Nathan DG: The acute and transient nature of idiopathic
331. Karlsson C, Hansson L, Celsing F, Lundin J: Treatment of severe refractory autoim- immune hemolytic anemia in childhood. J Pediatr 88:780, 1976.
mune hemolytic anemia in B-cell chronic lymphocytic leukemia with alemtuzumab 365. Zupanska B, Lawkowicz W, Gorska B, et al: Autoimmune haemolytic anemia in chil-
(humanized CD52 monoclonal antibody). Leukemia 21:511, 2007. dren. Br J Haematol 34:511, 1976.
332. Shumak KH, Rock GA: Therapeutic plasma exchange. N Engl J Med 310:762, 1984. 366. Heisel MA, Ortega JA: Factors influencing prognosis in childhood autoimmune hemo-
333. Council Report: Current status of therapeutic plasmapheresis and related techniques. lytic anemia. Am J Pediatr Hematol Oncol 5:147, 1983.
JAMA 253:819, 1985. 367. Carapella de Luca E, Casadei AM, DiPero G, et al: Autoimmune haemolytic anemia in
334. Cooling L, Boxer G, Simon R: Life-threatening autoimmune hemolytic anemia treated childhood: Follow-up in 29 cases. Vox Sang 36:13, 1979.
with manual whole blood exchange with rapid clinical improvement. J Blood Disord 368. Sokol RJ, Hewitt S, Stamps BK, Hitchen PA: Autoimmune haemolysis in childhood and
Transfus 4:163, 2013. adolescence. Acta Haematol 72:245, 1984.
335. Wouters A, Stephan F, Strengers P, et al: C1-esterase inhibitor concentrate rescues ery- 369. Aladjidi N, Leverger G, Leblanc T, et al: New insights into childhood autoimmune
throcytes from complement-mediated destruction in autoimmune hemolytic anemia. hemolytic anemia: A French national observational study of 265 children. Haematolog-
Blood 121:1242, 2014. ica 96:655, 2011.
336. Chao MP, Hong J, Kunder C, et al: Refractory warm IgM-mediated autoimmune hemo- 370. Wang WC: Evans syndrome in childhood: Pathophysiology, clinical course, and treat-
lytic anemia associated with Churg-Strauss Syndrome responsive to eculizumab and ment. Am J Pediatr Hematol Oncol 10:330, 1988.
rituximab. Am J Hematol 90:78, 2015.

Kaushansky_chapter 54_p0823-0846.indd 845 9/19/15 12:28 AM